CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythrodermic flare after the first dose of CoronaVac vaccine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233675 | PMC |
| http://dx.doi.org/10.34172/hpp.2021.32 | DOI Listing |
Publication Analysis
Top Keywords
generalized pustular
8
pustular psoriasis
8
psoriasis flare
8
psoriasis patient
8
patient developed
8
psoriasis
4
flare
4
flare coronavac
4
coronavac covid-19
4
covid-19 vaccination
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!